Reuters logo
BRIEF-Juno Therapeutics reports Q3 adjusted loss per share ‍$0.73​
November 1, 2017 / 8:48 PM / 24 days ago

BRIEF-Juno Therapeutics reports Q3 adjusted loss per share ‍$0.73​

Nov 1 (Reuters) - Juno Therapeutics Inc

* Juno Therapeutics reports third quarter 2017 financial results

* Juno Therapeutics Inc - qtrly ‍revenue $44.8 million versus $20.8 million​

* Juno Therapeutics Inc - qtrly loss per share ‍$1.12​

* Juno Therapeutics Inc - qtrly adjusted loss per share ‍$0.73​

* Juno Therapeutics Inc - ‍expects to be in lower half of 2017 cash burn guidance​

* Q3 earnings per share view $-0.80, revenue view $16.2 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below